DXCM vs. GEHC: DexCom vs. GE HealthCare Stock Comparison

Company Profile

DexCom (DXCM) and GE HealthCare (GEHC) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

DexCom (DXCM) has more than two decades of public-market history since April 14, 2005, whereas GE HealthCare (GEHC) listed on December 15, 2022 and has a much shorter record to draw on.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

DexCom (DXCM) has an aggressive beta of 1.43, indicating higher sensitivity to broad-market moves, while GE HealthCare (GEHC) is defensive at 0.69 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both DexCom (DXCM) at 37.67% and GE HealthCare (GEHC) at 20.01% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.

For every dollar of sales, both DexCom (DXCM) at 19.42% and GE HealthCare (GEHC) at 9.95% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

Both DexCom (DXCM) at 24.34% and GE HealthCare (GEHC) at 15.33% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

Profitability Metrics

Growth

Both DexCom (DXCM) at 15.60% and GE HealthCare (GEHC) at 4.84% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

DexCom (DXCM) at 47.18% sits in the top EPS growth quartile, while GE HealthCare (GEHC) at 4.84% is closer to the peer norm — faster per-share earnings growth for DXCM.

Growth Metrics

Financial Strength

DexCom (DXCM) at 1.74 keeps current ratio within its industry’s typical mid-range, while GE HealthCare (GEHC) at 1.30 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for GEHC.

Both DexCom (DXCM) at 0.55 and GE HealthCare (GEHC) at 0.88 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

DexCom (DXCM) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile GE HealthCare (GEHC) reports a yield of 0.17%, ranking against industry peers normally.

DexCom (DXCM) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile GE HealthCare (GEHC) reports a payout of 2.96%, ranking against industry peers normally.

Dividend Metrics

Valuation

GE HealthCare (GEHC) at 17.42 sits in the cheaper P/E ratio quartile, while DexCom (DXCM) at 31.26 is closer to its industry’s usual earnings multiple — a discount for GEHC, though growth and earnings durability still matter.

GE HealthCare (GEHC) at 1.72 is priced about in line with its industry on P/S ratio, while DexCom (DXCM) at 5.80 sits in the pricier quartile — DXCM costs more per dollar of sales.

GE HealthCare (GEHC) at 3.21 is valued about in line with its industry on P/B ratio, while DexCom (DXCM) at 11.68 carries an above-peer premium to book — DXCM is pricier on assets.

Valuation Metrics